SANGSTAT MEDICAL CORP risk profile
47 Elevated one input has moved against it
Measured 1 September 2026 from SANG's filed statements. Recomputed nightly.
47 (Elevated), driven by Market expectation at 66, over 5 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 66 | Stretched | Volatile | One-year price volatility — 45.1% |
| Operating pressure | 38 | Normal | Easing | Costs outgrowing revenue — +0.1 percentage points |
| Cash conversion | 20 | Normal | Stable | Capital spending against operating cash — 0.21x |
| Leverage and coverage | 32 | Normal | Easing | Current ratio — 0.86x |
| Competitive position | 51 | Elevated | Stable | Operating-margin gap against peers — +0.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Technology companies with a risk reading
NVIDIA Corp 24Apple Inc 48Microsoft Corporation 24Taiwan Semiconductor Manufacturing 22Broadcom Inc 20Micron Technology Inc 35Advanced Micro Devices Inc 34ASML Holding N.V. 30ASML Holding NV 25Intel Corp 68Palantir Technologies Inc - Class A 19Cisco Systems Inc 42
Financials, valuation and price history for SANGSTAT MEDICAL CORP